Skip to main content

2025 IDWeek Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Session Icons

Live Streamed

On Demand

66 Views

Z11. COVID-19 Vaccines

Poster Session: COVID-2019 and Co-Infections

(P-1657) Difference in reactogenicity events between mRNA and Protein-subunit Vaccines: Results from the Booster Epidemiological Evaluation of Health, Illness, and Vaccine Efficacy (BEEHIVE) Study, a U.S. randomized trial of 2023-2024 COVID-19 vaccines (XBB.1.5)

Wednesday, October 22, 2025

12:15 PM - 1:30 PM US ET

Location: Poster Hall B4-B5

Presenting Author(s)

Sarang K. Yoon, DO, MOH

Associate Professor
University of Utah School of Medicine
Salt Lake City, UT, United States

Co-Author(s)

MT

Matthew S. Thiese, PhD, MSPH

Professor
University of Utah - Rocky Mountain Center for Occupational and Environmental Health
Salt Lake City, Utah, United States
AP

Andrew Phillips, MD, MOH

University of Utah
Salt Lake City, Utah, United States
GE

German L. Ellsworth, MD, MPH, MOH

University of Utah
Salt Lake City, Utah, United States
SB

Sarah W. Ball, MPH, ScD

Westat
Newton, Massachusetts, United States
ER

Elizabeth Rowley, DrPH

Senior Biostatistician
Westat
Durham, North Carolina, United States
SB

Steph Battan-Wraith, PhD

Westat
Rockville, Maryland, United States
RF

Rebecca Fink, MPH

Senior Study Director
Westat
Rockville, Maryland, United States
AY

Adam Yates, PhD

Westat
Bethesda, Maryland, United States
ST

Seth Toback, M.D.

Novavax, Inc.
Gaithersburg, Maryland, United States
LD

Lisa M. Dunkle, MD

Vice President, Global Medical Lead
Novavax, Inc.
Gaithersburg, Maryland, United States
MR

Matthew D. Rousculp, PhD

Vice President, Real World Evidence, Medical Affairs
Novavax, Inc.
Gaithersburg, Maryland, United States
HZ

Hongwei Zhao, ScD

University of Utah
Salt Lake City, Utah, United States